Abstract:<h3 class="a-plus-plus">Abstract</h3> <span class="a-plus-plus abstract-section id-a-sec1"> <h3 class="a-plus-plus">Background</h3> <p class="a-plus-plus">Pneumococcal meningitis is associated with high mortality and morbidity rates. Up to 50% of survivors show neurologic sequelae including hearing loss, cognitive impairments and learning disabilities, being particularly detrimental in affected infants and children where adjuvant therapy with dexamethasone has no proven beneficial effect. We evaluated the effect of concomitantly targeting specific pathophysiological mechanisms responsible for brain damage—i.e. matrix-metalloproteinase (MMP) activity and the exacerbated cerebral inflammation provoked through antibiotic-induced bacterial lysis. Here, we combined adjunctive therapies previously shown to be neuroprotective when used as single adjuvant therapies.</p> </span> <span class="a-plus-plus abstract-section id-a-sec2"> <h3 class="a-plus-plus">Methods</h3> <p class="a-plus-plus">Eleven-day-old Wistar rats were infected intracisternally with 6.44 ± 2.17 × 10<sup class="a-plus-plus">3</sup> CFU <em class="a-plus-plus">Streptococcus pneumoniae</em> and randomised for treatment with ceftriaxone combined with (a) single adjuvant therapy with daptomycin (<em class="a-plus-plus">n</em> = 24), (b) single adjuvant therapy with Trocade (<em class="a-plus-plus">n</em> = 24), (c) combined adjuvant therapy (<em class="a-plus-plus">n</em> = 66) consisting of daptomycin and Trocade, or (d) ceftriaxone monotherapy (<em class="a-plus-plus">n</em> = 42). Clinical parameters and inflammatory CSF cytokine levels were determined during acute meningitis. Cortical damage and hippocampal apoptosis were assessed 42 h after infection. Morris water maze and auditory brainstem responses were used to assess neurofunctional outcome 3 weeks after infection.</p> </span> <span class="a-plus-plus abstract-section id-a-sec3"> <h3 class="a-plus-plus">Results</h3> <p class="a-plus-plus">We found significantly reduced apoptosis in the hippocampal subgranular zone in infant rats receiving adjuvant Trocade (<em class="a-plus-plus">p</em> < 0.01) or combined adjuvant therapy (<em class="a-plus-plus">p</em> < 0.001). Cortical necrosis was significantly reduced in rats treated with adjuvant daptomycin (<em class="a-plus-plus">p</em> < 0.05) or combined adjuvant therapy (<em class="a-plus-plus">p</em> < 0.05) compared to ceftriaxone monotherapy. Six hours after treatment initiation, CSF cytokine levels were significantly reduced for TNF-α (<em class="a-plus-plus">p</em> < 0.01), IL-1β (<em class="a-plus-plus">p</em> < 0.01), IL-6 (<em class="a-plus-plus">p</em> < 0.001) and IL-10 (<em class="a-plus-plus">p</em> < 0.01) in animals receiving combined adjuvant intervention compared to ceftriaxone monotherapy. Importantly, combined adjuvant therapy significantly improved learning and memory performance in infected animals and reduced hearing loss (77.14 dB vs 60.92 dB, <em class="a-plus-plus">p</em> < 0.05) by preserving low frequency hearing capacity, compared to ceftriaxone monotherapy.</p> </span> <span class="a-plus-plus abstract-section id-a-sec4"> <h3 class="a-plus-plus">Conclusion</h3> <p class="a-plus-plus">Combined adjuvant therapy with the non-bacteriolytic antibiotic daptomycin and the MMP inhibitor Trocade integrates the neuroprotective effects of both single adjuvants in experimental paediatric pneumococcal meningitis by reducing neuroinflammation and brain damage, thereby improving neurofunctional outcome. This strategy represents a promising therapeutic option to improve the outcome of paediatric patients suffering from pneumococcal meningitis.</p> </span>

Neuroprotective effects of brain-derived neurotrophic factor (BDNF) on hearing in experimental pneumococcal meningitis.

Regulation of Brain-Derived Neurotrophic Factor (BDNF) Expression Following Antibiotic Treatment of Experimental Bacterial Meningitis.

Expression of brain-derived neurotrophic factor at acute inflammatory injury of the brain

Brain-derived Neurotrophic Factor Combined with Neural Stem Cells Transplantation in Treatment of Severe Traumatic Brain Injury in Rats

Exogenous BDNF Increases Neurogenesis in the Hippocampus in Experimental Streptococcus Pneumoniae Meningitis.

The Severity of Infection Determines the Localization of Damage and Extent of Sensorineural Hearing Loss in Experimental Pneumococcal Meningitis

Selective Loss of Brain-Derived Neurotrophic Factor Exacerbates Brain Injury by Enhancing Neuroinflammation in Experimental <i>Streptococcus pneumoniae</i> Meningitis

The responsiveness of TrkB to exogenous BDNF in frontal cortex during antibiotic treatment of Streptococcus pneumoniae meningitis

Decrease in Rates of Hearing Loss From Pediatric Bacterial Meningitis Over Time: A Database Review

Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis

Brain-derived Neurotrophic Factor Reduces Inflammation and Hippocampal Apoptosis in Experimental Streptococcus Pneumoniae Meningitis

[Effect of brain-derived neurotrophic factor gene transfected bone-marrow mesenchymal stem cells on damaged cochlear spiral ganglion cells of guinea pigs]

Effect of topical dexamethasone on sensorineural hearing loss in endotoxin-induced otitis media

Delayed BDNF application in induced deafness in rats

Pneumococcal Meningitis Induces Hearing Loss and Cochlear Ossification Modulated by Chemokine Receptors CX3CR1 and CCR2

No Protective Effects of Hair Cells or Supporting Cells in Ototoxically Deafened Guinea Pigs upon Administration of BDNF

Brain-derived neurotrophic factor treatment does not improve functional recovery after hair cell regeneration in the pigeon

Therapeutic Value of Nerve Growth Factor in Promoting Neural Stem Cell Survival and Differentiation and Protecting Against Neuronal Hearing Loss

Complementary roles of neurotrophin 3 and a N-methyl-D-aspartate antagonist in the protection of noise and aminoglycoside-induced ototoxicity.

Early transtympanic administration of rhBDNF exerts a multifaceted neuroprotective effect against cisplatin‐induced hearing loss

Dynamic changes of TrkB gene expression in Streptococcus pneumoniae meningitis after treatment with antibiotics and dexamethasone